BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31585872)

  • 1. The role of mitochondria in cardiovascular diseases related to atherosclerosis.
    Glanz VY; Sobenin IA; Grechko AV; Yet SF; Orekhov AN
    Front Biosci (Elite Ed); 2020 Jan; 12(1):102-112. PubMed ID: 31585872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Dysfunction: The Hidden Player in the Pathogenesis of Atherosclerosis?
    Ciccarelli G; Conte S; Cimmino G; Maiorano P; Morrione A; Giordano A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis.
    Puddu P; Puddu GM; Galletti L; Cravero E; Muscari A
    Cardiology; 2005; 103(3):137-41. PubMed ID: 15665536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells.
    Roy Chowdhury SK; Sangle GV; Xie X; Stelmack GL; Halayko AJ; Shen GX
    Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E89-98. PubMed ID: 19843872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Dysfunction in Vascular Wall Cells and Its Role in Atherosclerosis.
    Salnikova D; Orekhova V; Grechko A; Starodubova A; Bezsonov E; Popkova T; Orekhov A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis.
    Puddu P; Puddu GM; Cravero E; De Pascalis S; Muscari A
    J Biomed Sci; 2009 Dec; 16(1):112. PubMed ID: 20003216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrion as a Selective Target for the Treatment of Atherosclerosis: Role of Mitochondrial DNA Mutations and Defective Mitophagy in the Pathogenesis of Atherosclerosis and Chronic Inflammation.
    Orekhov AN; Poznyak AV; Sobenin IA; Nikifirov NN; Ivanova EA
    Curr Neuropharmacol; 2020; 18(11):1064-1075. PubMed ID: 31744449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial DNA damage and atherosclerosis.
    Yu EP; Bennett MR
    Trends Endocrinol Metab; 2014 Sep; 25(9):481-7. PubMed ID: 25034130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Arterial-Wall-Specific Mechanisms in Atherosclerosis: Focus on Mitochondrial Mutations.
    Orekhov AN; Ivanova EA; Markin AM; Nikiforov NG; Sobenin IA
    Curr Atheroscler Rep; 2020 Aug; 22(10):54. PubMed ID: 32772280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction in atherosclerosis.
    Madamanchi NR; Runge MS
    Circ Res; 2007 Mar; 100(4):460-73. PubMed ID: 17332437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial reactive oxygen species and risk of atherosclerosis.
    Hulsmans M; Van Dooren E; Holvoet P
    Curr Atheroscler Rep; 2012 Jun; 14(3):264-76. PubMed ID: 22350585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial Respiration Is Reduced in Atherosclerosis, Promoting Necrotic Core Formation and Reducing Relative Fibrous Cap Thickness.
    Yu EPK; Reinhold J; Yu H; Starks L; Uryga AK; Foote K; Finigan A; Figg N; Pung YF; Logan A; Murphy MP; Bennett M
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2322-2332. PubMed ID: 28970293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Dysfunction in Atherosclerosis.
    Peng W; Cai G; Xia Y; Chen J; Wu P; Wang Z; Li G; Wei D
    DNA Cell Biol; 2019 Jul; 38(7):597-606. PubMed ID: 31095428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells.
    Gutierrez J; Ballinger SW; Darley-Usmar VM; Landar A
    Circ Res; 2006 Oct; 99(9):924-32. PubMed ID: 17068300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Mitochondrial Genome Associated with Predisposition to Atherosclerosis and Related Disease.
    Volobueva A; Grechko A; Yet SF; Sobenin I; Orekhov A
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31426564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria in vascular disease.
    Yu E; Mercer J; Bennett M
    Cardiovasc Res; 2012 Jul; 95(2):173-82. PubMed ID: 22392270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mitochondrial dysfunction on cellular function: Role in atherosclerosis.
    Xu M; Wang W; Cheng J; Qu H; Xu M; Wang L
    Biomed Pharmacother; 2024 May; 174():116587. PubMed ID: 38636397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications.
    Sobenin IA; Chistiakov DA; Bobryshev YV; Postnov AY; Orekhov AN
    Curr Pharm Des; 2013; 19(33):5942-53. PubMed ID: 23438955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Oxidative Stress, Mitochondrial DNA Damage and Their Role in Age-Related Vascular Dysfunction.
    Mikhed Y; Daiber A; Steven S
    Int J Mol Sci; 2015 Jul; 16(7):15918-53. PubMed ID: 26184181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and mitochondrial dysfunction in atherosclerosis: mitochondria-targeted antioxidants as potential therapy.
    Victor VM; Apostolova N; Herance R; Hernandez-Mijares A; Rocha M
    Curr Med Chem; 2009; 16(35):4654-67. PubMed ID: 19903143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.